Journey Medical Corp. (DERM)
6.29
+0.34
(+5.71%)
USD |
NASDAQ |
Oct 09, 16:00
6.29
0.00 (0.00%)
After-Hours: 17:15
Journey Medical Profit Margin (Quarterly) : -1.69% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.69% |
| March 31, 2026 | -13.97% |
| December 31, 2025 | -7.76% |
| September 30, 2025 | -13.13% |
| June 30, 2025 | -25.29% |
| March 31, 2025 | -31.00% |
| December 31, 2024 | 11.17% |
| September 30, 2024 | -16.34% |
| June 30, 2024 | -22.63% |
| March 31, 2024 | -80.14% |
| December 31, 2023 | -14.05% |
| September 30, 2023 | 48.61% |
| June 30, 2023 | -48.70% |
| Date | Value |
|---|---|
| March 31, 2023 | -82.99% |
| December 31, 2022 | -66.65% |
| September 30, 2022 | -62.55% |
| June 30, 2022 | -41.16% |
| March 31, 2022 | -5.92% |
| December 31, 2021 | -124.2% |
| September 30, 2021 | -54.29% |
| June 30, 2021 | -77.61% |
| March 31, 2021 | 2.50% |
| December 31, 2020 | 18.23% |
| September 30, 2020 | 0.31% |
| June 30, 2020 | 4.83% |
| March 31, 2020 | 19.23% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
| Johnson & Johnson | 21.86% |
| Eli Lilly & Co. | 30.88% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -21.81% |
| Return on Assets | -6.77% |
| Return on Invested Capital | -11.43% |
| Gross Profit Margin (Quarterly) | 61.58% |
| Operating Margin (Quarterly) | 2.46% |
| Return on Net Operating Assets | -9.68% |